Displaying drugs 16476 - 16500 of 16617 in total
Comosain
Investigational
LT2003
Investigational
EB003
EB003 is a CRISPR-based sequence-specific antimicrobial (SSAM) targeted against shiga toxin-producing E. coli.
Investigational
E1v1.11
E1v1.11 is an antisense oligonucleotide targeting the SMN2 gene which is under investigation for the treatment of spinal muscular atrophy (SMA).
Investigational
NXC680
NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).
Investigational
ART5803
ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.
Investigational
PYX-201
PYX-201 is an antibody-drug conjugate directed against the extra domain-B splice variant of fibronectin.
Investigational
MDX-1097
MDX-1097 is a chimeric monoclonal antibody directed against the kappa myeloma antigen (KMA).
Investigational
INBRX-101
INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein.
Investigational
GB-13
GB-13 is a genetically engineered recombinant protein consisting of an IL13Ra2-targeted genetically engineered mutant of IL-13 and PE4E, a derivative of Pseudomonas exotoxin A.
Investigational
LIS-1
LIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.
Investigational
Fenvalerate
Investigational
Iodine I-124 Evuzamitide
Investigational
Cemsidomide
Investigational
Zilovertamab
Investigational
Crisdesalazine
Investigational
ABBV-CLS-7262
Investigational
Fobrepodacin
Investigational
rAAV9-hNAGLU
rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase.
Investigational
BIIB115
BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.
Investigational
ZVS101e
ZVS101e is a recombinant adeno-associated virus vector carrying human CYP4V2 gene.
Investigational
Prolactin G129R
Investigational
Displaying drugs 16476 - 16500 of 16617 in total